ecrin-mdr-crcClinical2020IPD Sharing (as of October 2022): NoGastrointestinal Tract CancersColon LesionGastrointestinal NeoplasmsColon NeoplasmColorectal CancerAdenomaRectal CancerColon DiseasesRectal DiseasesColon CancerColorectal NeoplasmsColon PolypPolypsColonic NeoplasmsColonic DiseasesPolypGastrointestinal Tract CancersColon LesionColon NeoplasmGastrointestinal NeoplasmsColorectal CancerRectal CancerAdenomaColon DiseasesRectal DiseasesColon CancerColorectal NeoplasmsColon PolypPolypsColonic NeoplasmsColonic DiseasesPolypObservationalhttps://newmdr.ecrin.org/Study/2337748United StatesUnited Arab Emirates5Liquid BiopsyGenomicsArtificial IntelligenceCancer Early Detection TestMachine LearningColorectal Cancer ScreeningScreeningColorectal Cancer (CRC)Freenome TestCRCColonoscopyCancer ScreeningGenomics TestCancer DiagnosticBlood Test CancerECRIN MDRActive, not recruitingfalsePrevention of Colorectal Cancer Through Multiomics Blood TestingThe PREEMPT CRC study is a prospective multi-center observational study to validate a blood-based test for the early detection of colorectal cancer by collecting blood samples from average-risk participants who will undergo a routine screening colonoscopy.2020-05-152337748NCT04369053